SIRT1 Antibodies

Santa Cruz Biotechnology features a diverse variety of SIRT1 monoclonal antibodies for various research applications. SIRT1 Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SIRT1, or Sirtuin 1, is a NAD+-dependent deacetylase that plays a crucial role in cellular regulation, influencing processes such as aging, metabolism, and stress response. Through modulation of protein acetylation status, SIRT1 regulates gene expression, DNA repair, and apoptosis, making it a significant target in studies related to cancer, neurodegenerative diseases, and metabolic disorders. Understanding SIRT1 function is essential for advancing therapeutic strategies in these areas. SIRT1 research has revealed its importance in maintaining cellular homeostasis and its potential as a therapeutic target. Recent studies have highlighted SIRT1's role in neuroprotection and metabolic regulation. Ongoing research continues to uncover new functions and regulatory mechanisms of SIRT1 in various biological processes. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing SIRT1-related discoveries and therapeutic developments.